Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
- 1 March 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (3), 602-606
- https://doi.org/10.1161/01.str.0000155737.43566.ad
Abstract
Background— Growing data point toward intravenous tissue plasminogen activator (tPA) benefit after 3 hours in selected stroke patients. We aim to study safety and efficacy of tPA treatment in the 3...Keywords
This publication has 17 references indexed in Scilit:
- The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)Stroke, 2005
- Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated PatientsStroke, 2003
- Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 HoursStroke, 2002
- CT and Diffusion-Weighted MR Imaging in Randomized OrderStroke, 2002
- Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy studyAnnals of Neurology, 2002
- Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemiaAnnals of Neurology, 2001
- Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRIThe Lancet, 1999
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activatorNature, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993